4 Podcast Episodes
Journal Club VII-b: Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma (ECHELON-1) /m. gæst Martin Hutchings
Journal Club VII-b: Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma (ECHELON-1) /m. gæst Martin Hutchings
HæmatoLOGIK er henvendt til sundhedsfagligt personale.Dette er anden episode af HæmatoLOGIKs om Hodgkin's Lymfom. Gæsten... Read more
22 Feb 2023
•
51mins
Investigating Brentuximab Vedotin for Advanced-Stage Hodgkin Lymphoma With Habte Yimer, MD
Investigating Brentuximab Vedotin for Advanced-Stage Hodgkin Lymphoma With Habte Yimer, MD
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting ... Read more
16 Feb 2023
•
4mins
Updates on Trials of Zilovertamab and Brentuximab Vedotin in Lymphomas With Hun Lee, MD
Updates on Trials of Zilovertamab and Brentuximab Vedotin in Lymphomas With Hun Lee, MD
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting ... Read more
16 Feb 2023
•
8mins
FDA D.I.S.C.O. Burst Edition: FDA approval of Adcetris (brentuximab vedotin) in combination with chemotherapy for pediatric patients with classical Hodgkin lymphoma
FDA D.I.S.C.O. Burst Edition: FDA approval of Adcetris (brentuximab vedotin) in combination with chemotherapy for pediatric patients with classical Hodgkin lymphoma
FDA D.I.S.C.O. Burst Edition: FDA approval of Adcetris (brentuximab vedotin) in combination with chemotherapy for pediat... Read more
15 Dec 2022
•
3mins